- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05349604
Effect of Garlic Extracts on Changes in Blood Flow Velocity in the Carotid Artery
April 21, 2022 updated by: Yong-il Shin, Pusan National University Yangsan Hospital
Effect of Garlic Extracts on Changes in Blood Flow Velocity in the Carotid Artery: Randomized, Double-blind, Placebo-controlled Study
The purpose of this study is to assess the safety and efficacy of Garlic extracts for improving of blood flow velocity in the carotid artery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Yangsan
-
Gyeongsang, Yangsan, Korea, Republic of, 50610
- Pusan National University Yangsan Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy adults 19 years of age or older as of the screening date
- Those with no history of treatment for hypertension within the last 3 months
- A person who voluntarily decides to participate and agrees in writing to abide by the precautions after hearing and fully understanding the detailed explanation of this study
Exclusion Criteria:
- Those with systolic blood pressure of 160 mmHg or higher or diastolic blood pressure of 100 mmHg or higher
- Those who have had a stroke, myocardial infarction, percutaneous coronary angioplasty or surgery for coronary angioplasty within the past 6 months
- Persons with acute and severe cardiovascular diseases such as heart failure, myocardial infarction, and stroke
- Those with acute/chronic inflammation such as cancer, rheumatic disease, autoimmune disease, gastrointestinal disease, etc.
- Those who have a history of gastrointestinal diseases (eg Crohn's disease) or gastrointestinal surgery (except simple appendicectomy or hernia surgery) that may affect the absorption of the product for human application testing
- Persons who have taken prohibited concomitant drugs within the last 3 months
- Persons with a history of clinically significant hypersensitivity reactions to drugs and health functional foods
- Those who have received antipsychotic drug treatment within 2 months before the screening test
- Persons with a history of drug or alcohol abuse
- Pregnant or lactating women
- When women of childbearing potential of childbearing potential do not accept the implementation of appropriate contraceptive methods (except for women who have undergone sterilization)
- Subjects who have participated in health functional food related research or clinical trials within the last 3 months
- In case the principal investigator judges that it is not appropriate to participate in this study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Garlic extracts
Take 450mg of Garlic extracts(Food Item Making Report Product Name: Vegetable Extract Powder No. 1905, Item Report No.: 202004980275)
|
One intake in total
|
|
Placebo Comparator: placebo
As a food ingredient that does not affect blood pressure and is harmless to the human body, it is made almost identical in weight and appearance to garlic extract.
|
One intake in total
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of peak systolic blood flow velocity in the common carotid arteries
Time Frame: Change of peak systolic blood flow velocity before and after 60 minutes garlic extract intake basis in the experimental group
|
Doppler ultrasonography is used for measurement.
|
Change of peak systolic blood flow velocity before and after 60 minutes garlic extract intake basis in the experimental group
|
|
Change of end-diastolic blood flow velocity in the common carotid arteries
Time Frame: Change of end-diastolic blood flow velocity before and after 60 minutes garlic extract intake basis in the experimental group
|
Doppler ultrasonography is used for measurement.
|
Change of end-diastolic blood flow velocity before and after 60 minutes garlic extract intake basis in the experimental group
|
|
Change of diastolic and systolic blood pressure
Time Frame: Change of diastolic and systolic blood pressure before and after 60 minutes garlic extract intake basis in the experimental group
|
The blood pressure device is measured by IntelliVue MP50® from Philips.
When measuring blood pressure, the study subjects should sit comfortably for at least 5 minutes and then take the measurements.
The unit is mmHg and is expressed as an integer.
|
Change of diastolic and systolic blood pressure before and after 60 minutes garlic extract intake basis in the experimental group
|
|
Change of peak systolic blood flow velocity in the internal carotid arteries
Time Frame: Change of peak systolic blood flow velocity before and after 60 minutes garlic extract intake basis in the experimental group
|
Doppler ultrasonography is used for measurement.
|
Change of peak systolic blood flow velocity before and after 60 minutes garlic extract intake basis in the experimental group
|
|
Change of end-diastolic blood flow velocity in the internal carotid arteries
Time Frame: Change of end-diastolic blood flow velocity before and after 60 minutes garlic extract intake basis in the experimental group
|
Doppler ultrasonography is used for measurement.
|
Change of end-diastolic blood flow velocity before and after 60 minutes garlic extract intake basis in the experimental group
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 27, 2020
Primary Completion (Actual)
May 30, 2021
Study Completion (Actual)
May 30, 2021
Study Registration Dates
First Submitted
June 9, 2021
First Submitted That Met QC Criteria
April 21, 2022
First Posted (Actual)
April 27, 2022
Study Record Updates
Last Update Posted (Actual)
April 27, 2022
Last Update Submitted That Met QC Criteria
April 21, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 04-2020-038
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.